The Role of Endothelin in Experimental Cerebral Vasospasm
- 1 July 1995
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurosurgery
- Vol. 37 (1), 78-86
- https://doi.org/10.1227/00006123-199507000-00012
Abstract
ENDOTHELIN (ET) MAY play a role in vasospasm after subarachnoid hemorrhage (SAH). The aim of our study was to test whether the systemic administration of bosentan, a nonpeptidic ETA and ETB receptor antagonist, could reverse vasospasm without inducing hypotension. In rabbits (single-hemorrhage model) and in dogs (doublehemorrhage model), SAH was induced; after vasospasm was established, the animals received intravenously either saline or a 30 mg/kg bolus of bosentan. The cross-sectional area of the basilar artery was analyzed by quantitative angiography. In rabbits (n = 13), bosentan reversed basilar vasospasm to the same extent as did an intravertebral injection of sodium nitroprusside. In dogs (n = 10), bosentan reversed only 52 ± 10% of the vasospasm reversible by papaverine. Bosentan did not alter the heart rate or the arterial blood pressure in either the rabbits or the dogs. In the cerebrospinal fluid, SAH increased endothelin-1 (ET1) and big ET1 by 6 and 3.8 times, respectively; in the basilar artery, SAH increased ET1 concentration, big ET1 concentration, and ET-converting enzyme activity by 1.3, 2, and 2.7 times, respectively. In addition, a local involvement of ET was also suggested by the relaxing effect of bosentan on basilar artery rings from rabbits with SAH and not from control rabbits. Receptor binding studies performed on dog basilar arteries revealed a shift in the phenotype expression of ET receptors from the A to the B type after SAH. We conclude that ET plays a major role in SAH and that systemic ET blockade might selectively dilate spastic arteries.Keywords
This publication has 33 references indexed in Scilit:
- Does endothelin-1 play a role in the pathogenesis of cerebral vasospasm?Stroke, 1994
- Site specific regulation in the kidney of endothelin and its receptor subtypes by cyclosporineKidney International, 1994
- A Novel Endothelin ETA Receptor Antagonist, BQ-485, and Its Preventive Effect on Experimental Cerebral Vasospasm in DogsBiochemical and Biophysical Research Communications, 1993
- ETB receptors on aortic smooth muscle cells of spontaneously hypertensive ratsAmerican Journal of Physiology-Cell Physiology, 1993
- BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injectionLife Sciences, 1993
- Treatment of cerebral vasospasm with intra-arterial papaverineJournal of Neurosurgery, 1992
- Long term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma, and 24-h urine of patients with subarachnoid hemorrhageZeitschrift für Die Gesamte Experimentelle Medizin, 1992
- Biphasic constriction of rabbit basilar artery following experimental subarachnoid hemorrhage: A morphometric studySurgical Neurology, 1992
- Oxyhaemoglobin increases the production of endothelin-1 by endothelial cells in cultureEuropean Journal of Pharmacology, 1991
- Endothelin: a potential modulator of cerebral vasospasmEuropean Journal of Pharmacology, 1990